NEW YORK (GenomeWeb News) – Nanosphere today reported that its first-quarter revenues doubled year over year driven by new customer placements of its Verigene molecular diagnostics system and respiratory virus cartridges.

The Northbrook, Ill.-based firm reported total revenues of $1.3 million for the three months ended March 31, compared to $640,000 for the first quarter of 2011. It matched analysts' consensus estimate for revenues of $1.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.